Literature DB >> 30857840

Danon disease: Gender differences in presentation and outcomes.

Michela Brambatti1, Oren Caspi1, Alessandro Maolo1, Elliott Koshi1, Barry Greenberg1, Matthew R G Taylor2, Eric D Adler3.   

Abstract

BACKGROUND: Danon disease (DD) is a rare X-linked autophagic vacuolar myopathy, characterized by high penetrance and severe cardiomyopathy. Because of its rarity, the natural history (NH) is uncertain.
OBJECTIVES: We aimed to describe disease variability and outcomes through a systematic review of all published DD cases.
METHODS: Among 83 manuscripts in MEDLINE and EMBASE on DD cases published until October 2017, we identified 146 patients with positive genetic testing for DD or positive muscle biopsy in a relative of a genetically diagnosed proband.
RESULTS: 56 females and 90 males were identified. 92.5% of patients had cardiac abnormalities. Females presented with either hypertrophic cardiomyopathy (HCM, 70.3%) or dilated cardiomyopathy (DCM, 29.3%) whereas males presented with HCM 96.2% of the time. The composite outcome of death, heart transplant or ventricular assist devices occurred equally in both sexes (32% of females and 37% of males, p = 0.60) but later in females (median age 38 years) than in males (median age 21 years, p < 0.001). Whereas women present with isolated cardiac disease 73% of the time, in males DD was frequently multisystemic and presented as a triad of cognitive impairment, skeletal myopathy, and HCM in 42% of patients.
CONCLUSIONS: In this first systematic review of DD, we confirmed the severe morbidity and mortality associated with disease in both sexes. Women presented with both HCM and DCM and generally with isolated cardiac disease, whereas in men DD usually presented as HCM and was frequently multi-systemic. Further prospective NH studies will be required to confirm these findings.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Danon disease; Dilated cardiomyopathy; Gender; Genetic testing; Hypertrophic cardiomyopathy; LAMP2 mutation

Mesh:

Year:  2019        PMID: 30857840     DOI: 10.1016/j.ijcard.2019.01.020

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  LAMP2 Cardiomyopathy: Consequences of Impaired Autophagy in the Heart.

Authors:  Ronny Alcalai; Michael Arad; Hiroko Wakimoto; Dor Yadin; Joshua Gorham; Libin Wang; Elia Burns; Barry J Maron; William C Roberts; Tetsuo Konno; David A Conner; Antonio R Perez-Atayde; Jon G Seidman; Christine E Seidman
Journal:  J Am Heart Assoc       Date:  2021-08-28       Impact factor: 6.106

2.  Left Ventricular Noncompaction and Cardiogenic Shock.

Authors:  Felipe Kazmirczak; Cindy M Martin; Chetan Shenoy
Journal:  Circulation       Date:  2020-02-24       Impact factor: 29.690

Review 3.  Danon disease: a case report and literature review.

Authors:  Jiamin Xu; Zhu Li; Yihai Liu; Xinlin Zhang; Fengnan Niu; Hongyan Zheng; Lian Wang; Lina Kang; Kun Wang; Biao Xu
Journal:  Diagn Pathol       Date:  2021-05-01       Impact factor: 3.196

Review 4.  The Role of Autophagy in Skeletal Muscle Diseases.

Authors:  Qianghua Xia; Xubo Huang; Jieru Huang; Yongfeng Zheng; Michael E March; Jin Li; Yongjie Wei
Journal:  Front Physiol       Date:  2021-03-25       Impact factor: 4.566

5.  Four-dimensional echocardiography and left ventricular systolic strain measured via two-dimensional speckle-tracking for Danon disease: a case series.

Authors:  Ma Changsheng; Jiali Fan; Zhou Bingyuan; Zhou Jiawei; Wang Li; Fan Lin; Liao Yuping; Zhao Caiming
Journal:  Eur Heart J Case Rep       Date:  2021-11-16

Review 6.  Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?

Authors:  Valentina Lodato; Giovanni Parlapiano; Federica Calì; Massimo Stefano Silvetti; Rachele Adorisio; Michela Armando; May El Hachem; Antonino Romanzo; Carlo Dionisi-Vici; Maria Cristina Digilio; Antonio Novelli; Fabrizio Drago; Massimiliano Raponi; Anwar Baban
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-31

7.  Cardiac Magnetic Resonance Imaging in Danon Disease Cardiomyopathy.

Authors:  Marzia Rigolli; Andrew M Kahn; Michela Brambatti; Francisco J Contijoch; Eric D Adler
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-30

8.  Danon disease is an underdiagnosed cause of advanced heart failure in young female patients: a LAMP2 flow cytometric study.

Authors:  Jiri Gurka; Lenka Piherova; Filip Majer; Anna Chaloupka; Daniela Zakova; Ondrej Pelak; Alice Krebsova; Petr Peichl; Jan Krejci; Tomas Freiberger; Vojtech Melenovsky; Josef Kautzner; Tomas Kalina; Jakub Sikora; Milos Kubanek
Journal:  ESC Heart Fail       Date:  2020-07-13

9.  Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes.

Authors:  Giorgia Del Favero; Alois Bonifacio; Teisha J Rowland; Shanshan Gao; Kunhua Song; Valter Sergo; Eric D Adler; Luisa Mestroni; Orfeo Sbaizero; Matthew R G Taylor
Journal:  J Clin Med       Date:  2020-07-31       Impact factor: 4.241

10.  A case report of delayed diagnosis of danon disease: Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene.

Authors:  Ying Zhang; Hang Ren; Shanshan Zhou
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.